ARCHIVES

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

Fisher To Direct Wilmot CC

October 5, 2001

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014